Sethi S - Search Results

1

Predicting Regression of Barrett's Esophagus-Can All the King's Men Put It Together Again?

Tobi M, Khoury N, Al-Subee O, Sethi S, Talwar H, Kam M, Hatfield J, Levi E, Hallman J, Moyer MP, Kresty L, Lawson MJ, McVicker B. Tobi M, et al. Among authors: sethi s. Biomolecules. 2024 Sep 20;14(9):1182. doi: 10.3390/biom14091182. Biomolecules. 2024. PMID: 39334948 Free PMC article.

2

Serum prognostic biomarkers in head and neck cancer patients.

Lin HS, Siddiq F, Talwar HS, Chen W, Voichita C, Draghici S, Jeyapalan G, Chatterjee M, Fribley A, Yoo GH, Sethi S, Kim H, Sukari A, Folbe AJ, Tainsky MA. Lin HS, et al. Among authors: sethi s. Laryngoscope. 2014 Aug;124(8):1819-26. doi: 10.1002/lary.24567. Epub 2014 Jan 29. Laryngoscope. 2014. PMID: 24347532 Free PMC article.

3

Clinical implication of microRNAs in molecular pathology.

Sethi S, Ali S, Kong D, Philip PA, Sarkar FH. Sethi S, et al. Clin Lab Med. 2013 Dec;33(4):773-86. doi: 10.1016/j.cll.2013.08.001. Epub 2013 Oct 9. Clin Lab Med. 2013. PMID: 24267185 Review.

4

miR-20b is up-regulated in brain metastases from primary breast cancers.

Ahmad A, Ginnebaugh KR, Sethi S, Chen W, Ali R, Mittal S, Sarkar FH. Ahmad A, et al. Among authors: sethi s. Oncotarget. 2015 May 20;6(14):12188-95. doi: 10.18632/oncotarget.3664. Oncotarget. 2015. PMID: 25893380 Free PMC article.

5

Clinical advances in molecular biomarkers for cancer diagnosis and therapy.

Sethi S, Ali S, Philip PA, Sarkar FH. Sethi S, et al. Int J Mol Sci. 2013 Jul 16;14(7):14771-84. doi: 10.3390/ijms140714771. Int J Mol Sci. 2013. PMID: 23863689 Free PMC article. Review.

6

Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study.

Sethi S, Ali-Fehmi R, Franceschi S, Struijk L, van Doorn LJ, Quint W, Albashiti B, Ibrahim M, Kato I. Sethi S, et al. Int J Cancer. 2012 Sep 1;131(5):1179-86. doi: 10.1002/ijc.26500. Epub 2011 Nov 19. Int J Cancer. 2012. PMID: 22020866 Free PMC article.

7

Tumor-initiating cells and FZD8 play a major role in drug resistance in triple-negative breast cancer.

Yin S, Xu L, Bonfil RD, Banerjee S, Sarkar FH, Sethi S, Reddy KB. Yin S, et al. Among authors: sethi s. Mol Cancer Ther. 2013 Apr;12(4):491-8. doi: 10.1158/1535-7163.MCT-12-1090. Epub 2013 Feb 27. Mol Cancer Ther. 2013. PMID: 23445611 Free PMC article.

8

EZH2 blockade by RNA interference inhibits growth of ovarian cancer by facilitating re-expression of p21(waf1/cip1) and by inhibiting mutant p53.

Seward S, Semaan A, Qazi AM, Gruzdyn OV, Chamala S, Bryant CC, Kumar S, Cameron D, Sethi S, Ali-Fehmi R, Morris R, Bouwman DL, Munkarah AR, Weaver DW, Gruber SA, Batchu RB. Seward S, et al. Among authors: sethi s. Cancer Lett. 2013 Aug 9;336(1):53-60. doi: 10.1016/j.canlet.2013.04.012. Epub 2013 Apr 18. Cancer Lett. 2013. PMID: 23603558

9

Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes.

Kong D, Sethi S, Li Y, Chen W, Sakr WA, Heath E, Sarkar FH. Kong D, et al. Among authors: sethi s. Prostate. 2015 Feb;75(2):161-74. doi: 10.1002/pros.22901. Epub 2014 Oct 13. Prostate. 2015. PMID: 25307492 Free PMC article.

10

Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.

Ahmad A, Aboukameel A, Kong D, Wang Z, Sethi S, Chen W, Sarkar FH, Raz A. Ahmad A, et al. Among authors: sethi s. Cancer Res. 2011 May 1;71(9):3400-9. doi: 10.1158/0008-5472.CAN-10-0965. Epub 2011 Mar 9. Cancer Res. 2011. PMID: 21389093 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,238 results

Search Page

Filters